MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients-Reference-Cited by-同舟云学术

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients

Published:2015-07-02 Issue:28 Volume:6 Page:26278-26290
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lenos Kristiaan¹²,Goos Jeroen A.C.M.³,Vuist Ilona M.¹⁴,den Uil Sjoerd H.³⁵,Delis-van Diemen Pien M.³⁶,Belt Eric J.Th.⁷,Stockmann Hein B.A.C.⁵,Bril Herman⁸,de Wit Meike⁹⁶,Carvalho Beatriz³⁶,Giblett Susan¹⁰,Pritchard Catrin A.¹⁰,Meijer Gerrit A.³⁶,van Kooyk Yvette¹,Fijneman Remond J.A.³⁶,van Vliet Sandra J.¹

Affiliation:

1. Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands

2. Current address: Laboratory of Experimental Oncology and Radiobiology, Center for Experimental Molecular Medicine, Academic Medical Center, Amsterdam, The Netherlands

3. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

4. Current address: Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands

5. Department of Surgery, Spaarne Gasthuis, Haarlem, The Netherlands

6. Current address: Netherlands Cancer Institute, Amsterdam, The Netherlands

7. Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands

8. Department of Pathology, Spaarne Gasthuis, Haarlem, The Netherlands

9. Department of Medical Oncology, VU University Medical Center Amsterdam, The Netherlands

10. Department of Biochemistry, University of Leicester, Leicester, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pleiotropic CLEC10A: implications for harnessing this receptor in the tumor microenvironment;Expert Opinion on Therapeutic Targets;2024-07-02

2. Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer;Glycobiology;2024-05-24

3. Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?—A Way to Trick the Host’s Immune System;International Journal of Molecular Sciences;2023-12-03

4. Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease;Glycobiology;2023-10-17

5. Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma;Cancer Research Communications;2023-09-26